# Iveda Solutions, Inc.: financial statements, quarterly IVDA · Nasdaq · CIK 1397183 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ivda.md) · [Financials](/companies/ivda/financials.md) · [Filings](/companies/ivda/filings.md) · [Insiders](/companies/ivda/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ivda/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [873](/filings/0001493152-24-045941.md) | [1,026 d](/filings/0001641172-25-015284.md) | [347](/filings/0001641172-25-009950.md) | [1,534](/filings/0001641172-25-023965.md) | [2,398](/filings/0001493152-25-022582.md) | [1,742 d](/filings/0001493152-26-014179.md) | [1,475](/filings/0001493152-26-023706.md) | [1,528](/filings/0001493152-26-038440.md) | [1,652](/filings/0001493152-25-022582.md) | [626 d](/filings/0001493152-26-014179.md) | [1,494](/filings/0001493152-26-023706.md) | [802](/filings/0001493152-26-038440.md) | | Cost of revenue | $k | [731](/filings/0001493152-24-045941.md) | [868 d](/filings/0001641172-25-015284.md) | [165](/filings/0001641172-25-009950.md) | [1,033](/filings/0001641172-25-023965.md) | [1,988](/filings/0001493152-25-022582.md) | [1,534 d](/filings/0001493152-26-014179.md) | [1,186](/filings/0001493152-26-023706.md) | [1,083](/filings/0001493152-26-038440.md) | [1,135](/filings/0001493152-25-022582.md) | [603 d](/filings/0001493152-26-014179.md) | [999](/filings/0001493152-26-023706.md) | [363](/filings/0001493152-26-038440.md) | | Gross profit | $k | [142](/filings/0001493152-24-045941.md) | [158 d](/filings/0001641172-25-015284.md) | [182](/filings/0001641172-25-009950.md) | [501](/filings/0001641172-25-023965.md) | [410](/filings/0001493152-25-022582.md) | [208 d](/filings/0001493152-26-014179.md) | [288](/filings/0001493152-26-023706.md) | [445](/filings/0001493152-26-038440.md) | [517](/filings/0001493152-25-022582.md) | [22.6 d](/filings/0001493152-26-014179.md) | [495](/filings/0001493152-26-023706.md) | [439](/filings/0001493152-26-038440.md) | | Research and development | $k | not reported | not reported | [188](/filings/0001641172-25-009950.md) | [112](/filings/0001641172-25-023965.md) | [39.3](/filings/0001493152-25-022582.md) | [24.0 d](/filings/0001493152-26-014179.md) | [33.0](/filings/0001493152-26-023706.md) | [51.5](/filings/0001493152-26-038440.md) | [25.8](/filings/0001493152-25-022582.md) | [60.6 d](/filings/0001493152-26-014179.md) | [30.0](/filings/0001493152-26-023706.md) | [97.8](/filings/0001493152-26-038440.md) | | Selling, general and administrative | $k | [1,049](/filings/0001493152-24-045941.md) | [1,124 d](/filings/0001641172-25-015284.md) | [1,325](/filings/0001641172-25-009950.md) | [998](/filings/0001641172-25-023965.md) | [980](/filings/0001493152-25-022582.md) | [1,705 d](/filings/0001493152-26-014179.md) | [1,091](/filings/0001641172-25-009950.md) | [926](/filings/0001641172-25-023965.md) | [706](/filings/0001493152-25-022582.md) | [1,607 d](/filings/0001493152-26-014179.md) | not reported | not reported | | Operating income | $k | [(907)](/filings/0001493152-24-045941.md) | [(1,763) d](/filings/0001641172-25-015284.md) | [(1,332)](/filings/0001641172-25-009950.md) | [(608)](/filings/0001641172-25-023965.md) | [(609)](/filings/0001493152-25-022582.md) | [(1,521) d](/filings/0001493152-26-014179.md) | [(836)](/filings/0001493152-26-023706.md) | [(532)](/filings/0001493152-26-038440.md) | [(214)](/filings/0001493152-25-022582.md) | [(1,645) d](/filings/0001493152-26-014179.md) | [(566)](/filings/0001493152-26-023706.md) | [(710)](/filings/0001493152-26-038440.md) | | Interest expense | $k | [2.4](/filings/0001493152-23-040717.md) | [1.3 d](/filings/0001493152-24-012417.md) | [4.3](/filings/0001493152-24-020743.md) | [5.2](/filings/0001641172-25-023965.md) | [5.8](/filings/0001493152-25-022582.md) | [10.8 d](/filings/0001493152-26-014179.md) | [5.8](/filings/0001493152-26-023706.md) | [12.1](/filings/0001493152-26-038440.md) | [11.6](/filings/0001493152-25-022582.md) | [7.0 d](/filings/0001493152-26-014179.md) | [5.6](/filings/0001493152-26-023706.md) | [6.3](/filings/0001493152-26-038440.md) | | Income tax | $k | [(0.2)](/filings/0001493152-24-045941.md) | [(0.1) d](/filings/0001641172-25-015284.md) | [31.3](/filings/0001641172-25-009950.md) | [1.3](/filings/0001641172-25-023965.md) | [(0.1)](/filings/0001493152-25-022582.md) | [(0.1) d](/filings/0001493152-26-014179.md) | not reported | [29.8](/filings/0001493152-26-038440.md) | [0.7](/filings/0001493152-25-022582.md) | [0.0 d](/filings/0001493152-26-014179.md) | not reported | [114](/filings/0001493152-26-038440.md) | | Net income | $k | [(829)](/filings/0001493152-24-045941.md) | [(2,006) d](/filings/0001641172-25-015284.md) | [(1,290)](/filings/0001493152-25-022582.md) | [(599)](/filings/0001493152-25-022582.md) | [(581)](/filings/0001493152-25-022582.md) | [(1,511) d](/filings/0001493152-26-014179.md) | [(794)](/filings/0001493152-26-038440.md) | [(564)](/filings/0001493152-26-038440.md) | [(221)](/filings/0001493152-25-022582.md) | [(1,619) d](/filings/0001493152-26-014179.md) | [(533)](/filings/0001493152-26-038440.md) | [(793)](/filings/0001493152-26-038440.md) | | Diluted EPS | $ per share | [(0.41)](/filings/0001493152-24-045941.md) | not reported | [(0.64)](/filings/0001641172-25-009950.md) | [(0.30)](/filings/0001641172-25-023965.md) | [(0.27)](/filings/0001493152-25-022582.md) | not reported | [(0.28)](/filings/0001493152-26-023706.md) | [(0.20)](/filings/0001493152-26-038440.md) | [(0.07)](/filings/0001493152-25-022582.md) | not reported | [(0.06)](/filings/0001493152-26-023706.md) | [(0.07)](/filings/0001493152-26-038440.md) | | Basic EPS | $ per share | [(0.41)](/filings/0001493152-24-045941.md) | not reported | [(0.64)](/filings/0001641172-25-009950.md) | [(0.30)](/filings/0001641172-25-023965.md) | [(0.27)](/filings/0001493152-25-022582.md) | not reported | [(0.28)](/filings/0001493152-26-023706.md) | [(0.20)](/filings/0001493152-26-038440.md) | [(0.07)](/filings/0001493152-25-022582.md) | not reported | [(0.06)](/filings/0001493152-26-023706.md) | [(0.07)](/filings/0001493152-26-038440.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $k | [5,565](/filings/0001493152-23-040717.md) | [4,739](/filings/0001641172-25-015284.md) | [3,899](/filings/0001493152-24-020743.md) | [2,857](/filings/0001493152-24-032265.md) | [3,598](/filings/0001493152-24-045941.md) | [2,629](/filings/0001493152-26-014179.md) | [2,490](/filings/0001641172-25-009950.md) | [1,592](/filings/0001641172-25-023965.md) | [3,298](/filings/0001493152-25-022582.md) | [5,156](/filings/0001493152-26-038440.md) | [5,633](/filings/0001493152-26-023706.md) | [4,763](/filings/0001493152-26-038440.md) | | Current assets | $k | [6,939](/filings/0001493152-23-040717.md) | [5,909](/filings/0001641172-25-015284.md) | [5,279](/filings/0001493152-24-020743.md) | [5,330](/filings/0001493152-24-032265.md) | [7,634](/filings/0001493152-24-045941.md) | [5,026](/filings/0001493152-26-014179.md) | [4,213](/filings/0001641172-25-009950.md) | [4,085](/filings/0001641172-25-023965.md) | [5,481](/filings/0001493152-25-022582.md) | [6,156](/filings/0001493152-26-038440.md) | [7,526](/filings/0001493152-26-023706.md) | [6,668](/filings/0001493152-26-038440.md) | | Total assets | $k | [8,018](/filings/0001493152-23-040717.md) | [6,306](/filings/0001641172-25-015284.md) | [6,602](/filings/0001493152-24-020743.md) | [6,755](/filings/0001493152-24-032265.md) | [9,062](/filings/0001493152-24-045941.md) | [5,180](/filings/0001493152-26-014179.md) | [4,528](/filings/0001641172-25-009950.md) | [4,390](/filings/0001641172-25-023965.md) | [5,778](/filings/0001493152-25-022582.md) | [6,428](/filings/0001493152-26-038440.md) | [7,858](/filings/0001493152-26-023706.md) | [6,985](/filings/0001493152-26-038440.md) | | Current liabilities | $k | [1,338](/filings/0001493152-23-040717.md) | [1,658](/filings/0001641172-25-015284.md) | [1,477](/filings/0001493152-24-020743.md) | [2,078](/filings/0001493152-24-032265.md) | [3,111](/filings/0001493152-24-045941.md) | [2,298](/filings/0001493152-26-014179.md) | [2,339](/filings/0001641172-25-009950.md) | [2,403](/filings/0001641172-25-023965.md) | [1,577](/filings/0001493152-25-022582.md) | [1,267](/filings/0001493152-26-038440.md) | [1,660](/filings/0001493152-26-023706.md) | [1,284](/filings/0001493152-26-038440.md) | | Total liabilities | $k | not reported | [1,459](/filings/0001493152-24-045941.md) | [1,957](/filings/0001493152-24-020743.md) | [2,519](/filings/0001493152-24-032265.md) | [3,531](/filings/0001493152-24-045941.md) | [2,674](/filings/0001493152-25-022582.md) | [2,827](/filings/0001641172-25-009950.md) | [2,909](/filings/0001641172-25-023965.md) | [2,010](/filings/0001493152-25-022582.md) | [1,648](/filings/0001493152-26-038440.md) | [1,994](/filings/0001493152-26-023706.md) | [1,578](/filings/0001493152-26-038440.md) | | Long-term debt | $k | not reported | not reported | [480](/filings/0001493152-24-020743.md) | [441](/filings/0001493152-24-032265.md) | [420](/filings/0001493152-24-045941.md) | [376](/filings/0001493152-26-014179.md) | [341](/filings/0001641172-25-009950.md) | [365](/filings/0001641172-25-023965.md) | [306](/filings/0001493152-25-022582.md) | [266](/filings/0001493152-26-038440.md) | [230](/filings/0001493152-26-023706.md) | [199](/filings/0001493152-26-038440.md) | | Current portion of debt | $k | not reported | not reported | [125](/filings/0001493152-24-020743.md) | [123](/filings/0001493152-24-032265.md) | [126](/filings/0001493152-24-045941.md) | [122](/filings/0001493152-26-014179.md) | [120](/filings/0001641172-25-009950.md) | [126](/filings/0001641172-25-023965.md) | [131](/filings/0001493152-25-022582.md) | [128](/filings/0001493152-26-038440.md) | [125](/filings/0001493152-26-023706.md) | [126](/filings/0001493152-26-038440.md) | | Short-term borrowings | $k | [177](/filings/0001493152-23-040717.md) | [349](/filings/0001641172-25-015284.md) | [250](/filings/0001493152-24-020743.md) | [277](/filings/0001493152-24-032265.md) | [283](/filings/0001493152-24-045941.md) | [427](/filings/0001493152-26-014179.md) | [465](/filings/0001641172-25-009950.md) | [530](/filings/0001641172-25-023965.md) | [164](/filings/0001493152-25-022582.md) | [160](/filings/0001493152-26-038440.md) | not reported | [315](/filings/0001493152-26-038440.md) | | Shareholders' equity | $k | [6,680](/filings/0001493152-23-040717.md) | [4,648](/filings/0001493152-26-014179.md) | [3,321](/filings/0001493152-25-022582.md) | [2,816](/filings/0001493152-25-022582.md) | [4,098](/filings/0001493152-25-022582.md) | [2,505](/filings/0001493152-26-038440.md) | [1,701](/filings/0001493152-26-038440.md) | [1,481](/filings/0001493152-26-038440.md) | [3,768](/filings/0001493152-25-022582.md) | [4,780](/filings/0001493152-26-038440.md) | [5,864](/filings/0001493152-26-038440.md) | [5,407](/filings/0001493152-26-038440.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $k | [(2,733) d](/filings/0001493152-24-045941.md) | [(1,391) d](/filings/0001641172-25-015284.md) | [(1,293)](/filings/0001641172-25-009950.md) | [(1,000) d](/filings/0001641172-25-023965.md) | [(1,237) d](/filings/0001493152-25-022582.md) | [(890) d](/filings/0001493152-26-014179.md) | [(126)](/filings/0001493152-26-023706.md) | [(1,332) d](/filings/0001493152-26-038440.md) | [(317) d](/filings/0001493152-25-022582.md) | [(252) d](/filings/0001493152-26-014179.md) | [(927)](/filings/0001493152-26-023706.md) | [(1,437) d](/filings/0001493152-26-038440.md) | | Capital expenditure | $k | [(348) d](/filings/0001493152-24-045941.md) | [(6.1) d](/filings/0001641172-25-004833.md) | [188](/filings/0001493152-24-020743.md) | [114 d](/filings/0001493152-24-032265.md) | [(300) d](/filings/0001493152-24-045941.md) | [(0.0) d](/filings/0001641172-25-004833.md) | not reported | not reported | not reported | not reported | not reported | not reported | | Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: not reported ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [15.0](/filings/0001493152-23-040717.md) | [15.5](/filings/0001493152-24-020743.md) | [15.9](/filings/0001493152-24-032265.md) | [2.0](/filings/0001493152-24-045941.md) | [2.0](/filings/0001641172-25-009950.md) | [2.0](/filings/0001641172-25-023965.md) | [2.1](/filings/0001493152-25-022582.md) | [2.8](/filings/0001493152-26-023706.md) | [2.8](/filings/0001493152-26-038440.md) | [3.0](/filings/0001493152-25-022582.md) | [8.9](/filings/0001493152-26-023706.md) | [11.8](/filings/0001493152-26-038440.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 12,519,027 at 2026-08-10, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038440.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.